Atlas Trials

Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD

Clinical trial NCT05571267 · TERMINATED

Trial details

NCT number
NCT05571267
Sponsor
IVERIC bio, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neovascular Age-Related Macular Degeneration
Start date
2016-10-20
Primary completion
2018-04-24
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.